Promising clinical studies surrounding this compound, specifically the 120mg formulation branded as ZPHC, reveal a significant benefit on physique reduction and associated chronic factors. Experts believe that this dual compound, affecting both GLP-1 and GIP pathways , may provide a substantial improvement in the management of obesity and connecte